Browsing publications by Dr Mark Hudson

Newcastle AuthorsTitleYearFull text
Dr James Orr
Daniel Stow
Professor Fiona Matthews
Professor Barbara Hanratty
Professor David Jones
et al.
Eleven-year mortality and referral practices associated with abnormal alanine aminotransferase (ALT) results2016
Dr Louise Coats
Dr David Crossland
Dr Mark Hudson
Dr John O'Sullivan
Fontan conversion is a dated approach to the failing Fontan2016
Dr David Crossland
Dr Mark Hudson
Fontan-associated liver disease: Implications for heart transplantation2016
Dr Jessica Dyson
Dr Chris Lamb
Dr Steven Masson
Dr Mark Hudson
Dr Christian Dipper
et al.
Implementation of a “care bundle” improves the management of patients admitted to hospital with decompensated cirrhosis2016
Dr James Orr
Dr Mark Hudson
Natural History of Patients Taking Rifaximin-α for Recurrent Hepatic Encephalopathy and Risk of Future Overt Episodes and Mortality: A Post-hoc Analysis of Clinical Trials Data2016
Dr Jessica Dyson
Dr Mark Hudson
New metrics for the Lancet Standing Commission on Liver Disease in the UK2016
Dr Stuart McPherson
Dr Jessica Dyson
Dr Mark Hudson
Response to the NCEPOD report: development of a care bundle for patients admitted with decompensated cirrhosis—the first 24 h2016
Dr James Orr
Dr Mark Hudson
The impact on hospital resource utilisation of treatment of hepatic encephalopathy with rifaximin-alpha2016
Gourab Sen
Dr Mark Hudson
Professor Derek Manas
Umbilical Hernia Repair in Cirrhosis: Outcomes and Prognostic Factors in a Liver Transplant Unit2016
Dr James Orr
Dr Mark Hudson
Editorial: prolonged remission from hepatic encephalopathy with rifaximin2015
1234567891011